Recent studies have revealed that increasing lymphocytic infiltration in ER-/HER2- breast cancer has prognostic value and that programmed death-ligand-1 (PD-L1) upregulation is associated with improved survival in basal tumors [3,4]. Here, ERBB2 is linked to breast carcinoma.